VAERS Explorer
Back to explore

Report #2891754

Received Apr 6, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE)SANOFI PASTEURUNK

Symptoms (1)

Influenza

Symptom narrative

Flu; Initial information received on 09-Mar-2026 regarding an unsolicited valid non-serious case received from a nurse. This case involves a patient of unknown age and unknown gender who experienced flu after receiving INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (Fluzone HD). The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. On an unknown date, the patient received an unknown dose and unknown frequency of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] suspension for injection (batch and expiry: unknown) (strength: unknown) via unknown route in an unknown administration site for prophylactic vaccination (Immunisation). The patient experienced flu for a week (Influenza, onset: unknown, latency: unknown). Action taken: not applicable. Corrective treatment: not reported. Event outcome: unknown for influenza.

Medical history

Comments: NONE